Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Heron Therapeutics (HRTX) over the last 12 years, with Sep 2025 value amounting to $615,000.

  • Heron Therapeutics' Depreciation & Amortization (CF) rose 5.85% to $615,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 9.94%. This contributed to the annual value of $2.5 million for FY2024, which is 13.79% down from last year.
  • Latest data reveals that Heron Therapeutics reported Depreciation & Amortization (CF) of $615,000 as of Q3 2025, which was up 0.65% from $611,000 recorded in Q2 2025.
  • Heron Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $794,000 for Q4 2021, and its period low was $551,000 during Q1 2025.
  • In the last 3 years, Heron Therapeutics' Depreciation & Amortization (CF) had a median value of $641,000 in 2024 and averaged $652,455.
  • Per our database at Business Quant, Heron Therapeutics' Depreciation & Amortization (CF) rose by 19.00% in 2021 and then dropped by 20.08% in 2024.
  • Over the past 5 years, Heron Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $794,000 in 2021, then declined by 0.38% to $791,000 in 2022, then declined by 9.48% to $716,000 in 2023, then fell by 17.74% to $589,000 in 2024, then increased by 5.85% to $615,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $615,000 for Q3 2025, versus $611,000 for Q2 2025 and $551,000 for Q1 2025.